103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 35, Issue 5, 1996, Pages 875-879

  Dattoli, Michael ^a   Wallner, Kent ^b   Sorace, Richard ^a   Koval, John ^a   Cash, Jennifer ^a   Acosta, Rudolph ^a   Brown, Charles ^a   Etheridge, James ^a   Binder, Michael ^a   Brunelle, Richard ^a   Kirwan, Novelle ^a   Sanchez, Servando ^a   Stein, Douglas ^a   Wasserman, Stuart ^a  

^a University Community Hospital Tampa   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Brachytherapy; Dosimetry; Palladium; Prostatic carcinoma

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; DEXAMETHASONE; FLUTAMIDE; LEUPRORELIN; PALLADIUM; PROSTATE SPECIFIC ANTIGEN; RADIOISOTOPE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER STAGING; HIGH RISK PATIENT; HUMAN; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; RADIATION DOSE; RADIOISOTOPE THERAPY; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; URINE INCONTINENCE; BLOOD; BRACHYTHERAPY; MIDDLE AGED; PATHOLOGY; PENIS ERECTION; PROSTATE TUMOR; RADIATION EXPOSURE;

AGED; AGED, 80 AND OVER; BRACHYTHERAPY; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PALLADIUM; PENILE ERECTION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOISOTOPES; TUMOR MARKERS, BIOLOGICAL;

EID: 0030586032     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/0360-3016(96)00214-3     Document Type: Article

References (16)

1. 1. Blasko, J. C.; Wallner, K. E.; Grimm, P. D.; Ragde, H. PSA-based disease control following ultrasound-guided I-125 implantation for stage T1/T2 prostatic carcinoma. J. Urol. 154:1096-1099; 1995.
2. 2. Blasko, J. C.; Ragde, H.; Grimm, P. D. Transperineal ultrasound-guided implantation of the prostate: Morbidity and complications. Scand. J. Urol. Nephrol. Suppl. 137:113-118; 1991.
3. 3. Blasko, J. C.; Ragde, H.; Schumacher, D. Transperineal percutaneous iodine-125 implantation for prostatic carcinoma using transrectal ultrasound and template guidance. Endo/ Hyperthermia 3:131-139; 1987.
4. 4. Chilton, C. P.; Morgan, R. J.; England, H. R.; Paris, A. M. I.; Blandy, J. P. A critical evaluation of the results of transurethral resection of the prostate. Br. J. Urol. 50:542-546; 1978.
5. 5. delRegato, J. A. Radiotherapy in the conservative treatment of operable and locally inoperable carcinoma of the prostate. Radiology 88:761-766; 1967.
6. 6. Foote, J.; Yun, S.; Leach, G. E. Postprostatectomy incontinence: Pathophysiology, evaluation and management. Urol. Clin. North Am. 18:229-241; 1991.
7. 7. Gibbons, R. P.; Mason, J. T.; Correa, R. J.; Cummings, K. B.; Taylor, W. J.; Hafermann, M. D.; Richardson, R. G. Carcinoma of the prostate: Local control with external beam radiation therapy. J. Urol. 121:310-312; 1979.
8. 8. Holtgrewe, H. L.; Mebust, W. K.; Dowd, J. B.; Cockett, A. T. K.; Peters, P. C.; Proctor, C. Transurethral prostatectomy: Practice aspects of the dominant operation in American urology. J. Urol. 141:248-253; 1989.
9. 9. Kaplan, E. L.; Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:457-481; 1958.
10. 10. Meyhoff, H. H.; Nordling, J. Long term results of transurethral and transvesical prostatectomy: A randomized study. Scan. J. Urol. Nephrol. 20:27-33; 1986.
11. 11. Ferez, C. A.; Walz, B. J.; Zivnuska, F. R.; Pilepich, M.; Prasad, K.; Bauer, W. Irradiation of carcinoma of the prostate localized to the pelvis: Analysis of tumor response and prognosis. Int. J. Radiat. Oncol. Biol. Phys. 6:555-563; 1980.
12. 12. Pilepich, M. V.; Perez, C. A.; Walz, B. J.; Zivnuska, F. R. Complications of definitive radiotherapy for carcinoma of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 7:1341-1348; 1981.
13. 13. Seymore, C. H.; El-Mahdi, A. M.; Schellhammer, P. F. The effect of prior transurethral resection of the prostate on post radiation urethral strictures and bladder neck contractures. Int. J. Radiat. Oncol. Biol. Phys. 12:1597-1600; 1986.
14. 14. Wallner, K. E.; Roy, J.; Harrison, L. Tumor control and morbidity following transperineal I-125 implantation for Stage T1/T2 prostatic carcinoma. J. Clin. Oncol. 14; 1996.
15. 15. Wallner, K. E.; Roy, J.; Zelefsky, M.; Fuks, Z.; Harrison, L. Fluoroscopic visualization of the prostatic urethra to guide transperineal prostate implantation. Int. J. Radiat. Oncol. Biol. Phys. 29:863-867; 1994.
16. 16. Wallner, K. E.; Roy, J.; Zelefsky, M.; Fuks, Z.; Harrison, L. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 32:465-471; 1995.